Description: Össur hf., together with its subsidiaries, designs, develops, produces, and sells non-invasive orthopedic products in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. It offers prosthetics products, including artificial limbs and related products for amputees; and lower and upper limb prosthetic components, including feet, knees, hands, fingers, liners, and other components. The company also provides bracing and supports products, such as supporting devices for spinal, knee, hip, foot, ankle, and hands that are primarily used to support joints and other body parts for therapeutic and preventative purposes; and injury solutions to enhance the healing process of bone and soft tissue injuries. It serves specialized healthcare providers, including orthopedic and prosthetic clinics, hospitals, and surgery centers. The company sells its products through its direct sales networks and distributors. Össur hf. was founded in 1971 and is headquartered in Reykjavik, Iceland. Össur hf. is a subsidiary of William Demant Invest A/S.
Home Page: www.ossur.com
Grjothals 1-5
Reykjavik,
Iceland
Phone:
354 515 1300
Officers
Name | Title |
---|---|
Mr. Sveinn Solvason | Pres & CEO |
Mr. Ossur Kristinsson | Founder |
Ms. Gudny Arna Sveinsdottir | Chief Financial Officer |
Mr. Egill Jonsson | Exec. VP of Manufacturing & Operations |
Edda Lara Luovigsdottir | Investor Relations Director |
Ms. Sigurborg Arnarsdottir | Compliance Officer |
Ms. Margret Lara Fridriksdottir | Exec. VP of HR & Corp. Strategy |
Mr. Olafur Gylfason | Exec. VP of Prosthetics & Europe/Emerging Markets |
Mr. Gudjon G. Karason | Exec. VP of Clinics |
Mr. Christian Robinson | Exec. VP of Bracing & Supports and Americas |
Exchange: PINK
Country: US
Currency: US Dollar ($)
Forward PE: | 0 |
---|---|
Trailing PE: | 42.0909 |
Price-to-Book MRQ: | 3.203 |
Price-to-Sales TTM: | 2.7206 |
IPO Date: | |
Fiscal Year End: | December |
Full Time Employees: | 4000 |